Table 4.
Virologic outcomes among individuals with a viral load < 50 copies/mL at initiation, overall, and by the occurrence of any injection delays during follow-up
| Overall N = 273 |
No delayed injectionsa N = 208 |
Any delayed injectionsb N = 65 |
p value | |
|---|---|---|---|---|
| ≥ 1 follow-up viral load, n (%) | 221 (81) | 165 (79) | 56 (86) | |
| Median months from 1st injection to last viral load (IQR) | 2.8 (1.1, 5.1) | 2.2 (1.1, 4.7) | 4.3 (1.8, 6.9) | |
| Last viral load < 50 copies/mL, n (%) | 210 (95) | 157 (94) | 53 (95) | 0.85 |
| Last viral load < 200 copies/mL, n (%) | 218 (99) | 163 (99) | 55 (98) | 0.74 |
| All viral load < 200 copies/mL, n (%) | 213 (96) | 160 (97) | 53 (95) | 0.44 |
| Confirmed virologic failure, n (%) | 4 (2) | 3 (2) | 1 (2) | 0.96 |
IQR interquartile range, Nn number
aAll continuation injections were administered ≤ 7 days after target date
bAt least one continuation injection was administered > 7 days after target date